“Safety and Efficacy of Subretinal AAV-CRISPR Cas9 Gene Editing for Rhodopsin-Mutant Retinitis Pigmentosa: A Phase I IIa Dose-Escalation Triall”. Sriwijaya Journal of Ophthalmology 8, no. 2 (June 19, 2026): 478–485. Accessed July 30, 2026. https://www.sriwijayaopthalmology.com/index.php/sjo/article/view/137.